Skip to main content
رجوع
Watch Compare

ELITE PHARMACEUTICALS INC /NV/

جودة البيانات: 100%
ELTP
OTC Manufacturing Chemicals
KWD 0.38
KWD 0.00 (0.00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
34.90%

النمو

Revenue Growth (5Y)
34.90%
أعلى من متوسط القطاع (1.72%)
Revenue (1Y)48.42%
Earnings (1Y)-121.46%
FCF Growth (3Y)N/A

الجودة

Return on Equity
61.18%
أعلى من متوسط القطاع (-54.68%)
ROIC35.81%
Net Margin30.98%
Op. Margin35.74%

الأمان

Debt / Equity
N/A
Current Ratio7.34
Interest Coverage440.71

التقييم

PE (TTM)
9.43
أعلى من متوسط القطاع (-1.50)
P/B Ratio5.10
EV/EBITDA7.99
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 34.90% annually over 5 years — strong growth
Earnings declined -121.46% over the past year
ROE of 61.18% indicates high profitability
Net margin of 30.98% shows strong profitability
Generating 17.24 M in free cash flow
P/E of 9.43 — trading at a low valuation

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

مفاجآت الأرباح

EPS
Reported Estimate
Q22010 Q32010 Q42010
Reported -KWD 0.05 KWD 0.01 KWD 0.02
Estimate — — —
المفاجأة — — —

Growth

Rev 5Y: 34.90% · Earnings 1Y: -121.46%
Revenue Growth (1Y) 48.42% Revenue Growth (3Y) 56.86%
Earnings Growth (1Y) -121.46% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 34.90% Earnings Growth (5Y) N/A

Profitability

ROE: 61.18% · Net Margin: 30.98%
Revenue (TTM) 140.12 M Net Income (TTM) 43.41 M
ROE 61.18% ROA 35.63%
Gross Margin 51.06% Operating Margin 35.74%
Net Margin 30.98% Free Cash Flow (TTM) 17.24 M
ROIC 35.81% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 7.34
Debt / Equity N/A Current Ratio 7.34
Interest Coverage 440.71 Asset Turnover 1.15
Working Capital 83.60 M Tangible Book Value 74.68 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: 9.43 · EV/EBITDA: 7.99
P/E Ratio 9.43 Forward P/E N/A
P/B Ratio 5.10 P/S Ratio 2.92
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 7.99 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 4.21%
Market Cap 409.26 M Enterprise Value 409.26 M

Per Share

EPS: 0.04 · FCF/Share: 0.02
EPS (Diluted TTM) 0.04 Revenue / Share 0.13
FCF / Share 0.02 OCF / Share 0.02
EPS CAGR (1Y) -100.00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 39.71% · CapEx/Rev: 0.91%
CapEx / Revenue 0.91% FCF Conversion 39.71%
SBC-Adj. FCF N/A Growth Momentum 13.52

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 84.04 M 56.63 M 34.16 M 32.26 M 25.38 M
Net Income -4.31 M 20.11 M 3.56 M 8.90 M 5.09 M
EPS (Diluted) 0.00 0.02 0.00 0.01 0.01
Gross Profit 40.09 M 26.36 M 16.59 M 14.80 M 11.87 M
Operating Income 19.60 M 10.79 M 3.68 M 5.07 M 2.10 M
EBITDA — — — — —
R&D Expenses 7.96 M 6.88 M 6.20 M 4.05 M 5.11 M
SG&A Expenses — — — — —
D&A 1.23 M 1.32 M 1.28 M 1.21 M 1.31 M
Interest Expense 128,234.0 588,622.0 1.11 M 191,816.0 259,598.0
Income Tax 4.26 M -19.65 M 424,028.0 -1.74 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 96.39 M 83.65 M 40.90 M 35.15 M 26.19 M
Total Liabilities 42.87 M 26.07 M 11.94 M 9.93 M 10.04 M
Shareholders' Equity 53.52 M 57.58 M 28.96 M 25.22 M 16.15 M
Total Debt — — — 1.36 M 1.47 M
Cash & Equivalents — 7.11 M 7.83 M 8.54 M 3.19 M
Current Assets 57.74 M 40.01 M 21.51 M 18.86 M 12.19 M
Current Liabilities 11.84 M 13.05 M 7.83 M 6.69 M 5.81 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E 9.4 -1.5
P/B 5.1 1.6
ROE % 61.2 -54.7
Net Margin % 31.0 -41.5
Rev Growth 5Y % 34.9 1.7
D/E — 0.3

درجات الاستراتيجيات

1 strategy matched
Growth Capital Light Compounder
#11 of 85
52

النشاط الأخير

دخل Capital Light Compounder
Apr 12, 2026